Farringdon Capital, Ltd. Ardelyx, Inc. Transaction History
Farringdon Capital, Ltd.
- $242 Billion
- Q4 2024
A detailed history of Farringdon Capital, Ltd. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 15,992 shares of ARDX stock, worth $92,593. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,992Holding current value
$92,593% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ARDX
# of Institutions
231Shares Held
149MCall Options Held
1.65MPut Options Held
2.31M-
Janus Henderson Group PLC London, X024.4MShares$141 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$102 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$83.2 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$67.1 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$59.9 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $895M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...